Silo Pharma Partners with Resyca for Nasal Spray Device Study to Advance PTSD Treatment SPC-15

Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel ther...

May 22, 2025 | Thursday | News
Synfini and Multispan Join Forces to Accelerate GPCR Drug Discovery Using AI and Automation

Synfini, Inc., the leader in AI-driven agile chemistry for better molecule discovery, announced today that it has entered a collaboration with biotechnol...

May 22, 2025 | Thursday | News
Johnson & Johnson’s DARZALEX FASPRO® Receives ODAC Support for High-Risk Smoldering Multiple Myeloma

ODAC recommendation based on the positive progression-free survival and clinical benefit in the Phase 3 AQUILA study If approved, DARZALEX FASPRO® w...

May 21, 2025 | Wednesday | News
FedEx Becomes First Global Integrator to Earn CEIV Pharma Certification Across Entire Air Network

FedEx becomes first global integrator to achieve CEIV Pharma certification for ground handling across its air hubs and ramps. FedEx Corp. anno...

May 21, 2025 | Wednesday | News
Rani Therapeutics and Chugai Pharmaceutical Collaborate to Evaluate Oral Biologics Delivery via RaniPill®

Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs,  announced the compa...

May 21, 2025 | Wednesday | News
Signios Biosciences and Illumina Launch Grant for Early Access to Protein Prep 9.5K™ Platform

Signios Biosciences (“Signios Bio”), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaborat...

May 20, 2025 | Tuesday | News
Bayer Secures FDA Approval to Expand Jivi® Use in Children With Hemophilia A

-Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Jivi®, a recombinant DNA-derived, extended half-life factor VIII conce...

May 20, 2025 | Tuesday | News
Brain Cancer Canada Awards $68,000 to Advance Neoantigen-Based Vaccine Research for Deadly Childhood Brain Tumors

Brain Cancer Canada is pleased to award $68,000 for an innovative research initiative led by Dr. Aru Narendran, MD, PhD, and Dr. Patrick Sipila, PhD, at ...

May 19, 2025 | Monday | News
FDA Clears First Blood Test for Alzheimer’s Diagnosis, Marking a Milestone in Early Detection and Precision Care

FDA's approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against Alzheimer's disease. This is the f...

May 19, 2025 | Monday | News
Fujirebio Receives FDA Clearance for First Blood-Based Test to Aid Alzheimer’s Diagnosis in the U.S.

Fujirebio announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/&beta...

May 19, 2025 | Monday | News
AAFA Raises Alarm on MFN Drug Pricing Policy, Cites Risk to Patient Access

The Asthma and Allergy Foundation of America (AAFA) appreciates the President’s Executive Order calling attention to America’s persistent pro...

May 16, 2025 | Friday | News
Invivyd Urges FDA to Modernize COVID-19 Vaccine Evaluation Through Citizen Petition

Invivyd, Inc. announced it has submitted a Citizen Petition with the U.S. Food and Drug Administration (FDA) calling on the Agency to evolve from histori...

May 15, 2025 | Thursday | News
Silo Pharma Engages Veloxity Labs to Advance IND-Enabling Study for PTSD Treatment Candidate SPC-15

Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems,  announced that it has e...

May 15, 2025 | Thursday | News
Ecolab Opens Bioprocessing Applications Lab in Eastern U.S. to Boost Biotherapeutic Purification Support

  The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecu...

May 15, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close